Cirrus Logic enters its Q4 2026 earnings week — results due May 6 — with a stock that has pulled back sharply from its April highs and a short position that quietly rebuilt itself over the past week.
The week's most interesting tension is the divergence between a strong one-month price recovery and a renewed build in short interest, right as the clock ticks toward the next earnings catalyst.
The positioning picture shows bears adding cautiously but not aggressively. Short interest climbed nearly 9% over the week to 5.76% of the free float — reversing a stretch of steady cover-buying through late March and early April, when SI had retreated from above 6.2% to a low of around 5.1% on April 23. That April dip looks like shorts stepping aside ahead of a potential beat; the quick rebuild since then suggests that thesis has cooled. Borrowing costs remain muted at 0.45% — barely moved on a one-month basis — and availability in the lending market is loose, meaning there is little mechanical pressure on existing shorts. The ORTEX short score of 43.7, drifting higher through the week from 41.5, is broadly neutral: this is a stock with a real short base, not an extreme position in either direction.
Options traders moved more defensively on Tuesday. The put/call ratio jumped to 0.45, well above its 20-day average of 0.35 and the highest single-day reading in several weeks. For context, the PCR had been running below 0.16 for most of the period from April 20 to 24 — a stretch of unusually call-heavy flow. Tuesday's spike looks like late-week hedging ahead of the May 6 print, not a sustained re-rating of sentiment. The 52-week range of 0.12 to 0.90 puts Tuesday's reading squarely in the middle of the band, so this is caution, not alarm.
The analyst community is constructive but measured. Both Stifel and Keybanc raised targets in April — Stifel to $175 from $163 on April 16, Keybanc to $175 from $150 on April 6 — while maintaining positive ratings. Barclays sits at Equal-Weight with a $120 target, a meaningful discount to the current $162.51. The consensus mean target of $160 is essentially in line with the current price, implying the Street sees limited near-term upside on a blended basis. The EV/EBITDA multiple of 10.4x has contracted by about a turn over the past month as the stock ran higher — a sign the re-rating is being walked back. The PE of 17.9x is not stretched for a semiconductor name of this quality, and the EV/EBIT percentile score of 88 flags that the stock ranks as genuinely inexpensive relative to peers on that metric.
The structural bull case rests heavily on Apple dependence — 94% of quarterly revenue — being offset by expanding product breadth into amplifiers, haptics, power conversion, and automotive applications. Bears point to a GAAP gross margin expected around 52% and operating expense creep, which could compress profitability if the revenue mix shifts. Neither argument is new. What will matter on May 6 is whether the audio content per iPhone cycle is holding up and whether any pull-forward in the prior quarter has created a tougher compare.
History adds some flavour here. The last two quarterly results both produced positive one-day reactions: the February 2026 print delivered a 3.4% gain on the day and extended to 8.8% over five sessions; the result before that — February 2026's Q3 print — moved the stock 12.5% on the first day and 13.3% over the following week. Neither print prompted selling. That track record is not lost on the option bulls who were buying calls heavily through last week before Tuesday's hedging shift.
With the stock down 4.3% on the week to $162.51 despite a 13% one-month gain, the May 6 report is set to determine whether the recent rebuild in short interest was prescient or early.
See the live data behind this article on ORTEX.
Open CRUS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
